↓ Skip to main content

An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer

Overview of attention for article published in Breast Cancer Research, June 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
43 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer
Published in
Breast Cancer Research, June 2014
DOI 10.1186/bcr3668
Pubmed ID
Authors

Misako Sato, Mitsutaka Kadota, Binwu Tang, Howard H Yang, Yu-an Yang, Mengge Shan, Jia Weng, Michael A Welsh, Kathleen C Flanders, Yoshiko Nagano, Aleksandra M Michalowski, Robert J Clifford, Maxwell P Lee, Lalage M Wakefield

Abstract

Transforming growth factor-betas (TGF-betas) play a dual role in breast cancer, with context-dependent tumor suppressive or pro-oncogenic effects. TGF-beta antagonists are showing promise in early phase clinical oncology trials to neutralize the pro-oncogenic effects. However, there is currently no way to determine whether the tumor suppressive effects of TGF-beta are still active in human breast tumors at the time of surgery and treatment, a situation that could lead to adverse therapeutic responses.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
China 1 2%
France 1 2%
Unknown 39 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 28%
Researcher 11 26%
Student > Bachelor 5 12%
Student > Master 3 7%
Student > Doctoral Student 2 5%
Other 7 16%
Unknown 3 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 30%
Medicine and Dentistry 7 16%
Biochemistry, Genetics and Molecular Biology 5 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Nursing and Health Professions 2 5%
Other 7 16%
Unknown 6 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2015.
All research outputs
#16,721,717
of 25,374,647 outputs
Outputs from Breast Cancer Research
#1,480
of 2,053 outputs
Outputs of similar age
#138,668
of 241,454 outputs
Outputs of similar age from Breast Cancer Research
#20
of 33 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,053 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,454 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.